ReviewEuropean journal of microbiology & immunology2026
Ginger and derivatives as promising antibiotics-independent options to tackle infections caused by bacterial including multi-drug resistant pathogens - A review.
Review in European journal of microbiology & immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Antimicrobial Strategies in the Era of Resistance: It Is Too Early to Give Up Antibiotic Therapy.International journal of molecular sciences · 2026Review
- Antibacterial Efficacy of 6-Gingerol Alone and in Combination With Enrofloxacin Against Multidrug-Resistant Staphylococcus aureus Isolated From Goats.Veterinary medicine and science · 2026Article
- Bioactive Compounds of Ginger (Antibiotics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotics have revolutionized medicine and drastically reduced mortality from bacterial infections. However, the widespread misuse of antibiotics in human and veterinary medicine, but also farming has greatly accelerated the emergence of multidrug-resistant (MDR) pathogens hampering treatment of infectious diseases. Therefore, novel anti-infectious treatment concepts applying antibiotic-independent natural compounds are highly appreciated. Ginger (Zingiber officinale Roscoe) has been proposed as such promising candidate given its health-beneficial including anti-microbial effects. Therefore, our systematic literature review summarizes current evidence for anti-bacterial effects of ginger and derived molecules to elaborate perspectives for treatment options of infectious diseases caused by bacterial pathogens. The included 22 articles revealed that defined ginger extracts, essential oils, and distinct molecules including gingerol and shogaol i) inhibited growth of Gram-positive and Gram-negative bacteria including MDR isolates and ii) reduced distinct bacterial virulence factors including biofilm formation. Furthermore, iii) application of ginger together added to other plant-derived compounds or synthetic antibiotics markedly enhanced anti-bacterial effects of the latter, whereas iv) ginger could also exert immune-modulatory including anti-inflammatory and anti-oxidant activities in vitro and in vivo. In conclusion, ginger-derived molecules constitute promising alternative or adjunct antibiotics-independent options in the combat of infectious diseases caused by bacterial pathogens including MDR strains.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.